Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Daniel Ahn's Talks
Daniel Ahn
Mayo Clinic Arizona
tovecimig meets primary endpoint in BTC
April 2, 2025
Daniel Ahn
Mayo Clinic Arizona
00:00
--:--
cabozantinib new FDA approval for NET
March 28, 2025
Share
cabozantinib new FDA approval for NET
https://www.medspoke.co/channel_playlist?object_id=684&tap_id=12355
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Daniel Ahn
Mayo Clinic Arizona
tislelizumab approved in ESCC
March 16, 2025
Why are you reporting this TALK?
